# Staph Intervention for Effective Local Defense

> **NCT06210594** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 78 (actual)

## Conditions studied

- Staphylococcus Aureus Infection

## Interventions

- **COMBINATION_PRODUCT:** Mupirocin + Nozin + chlorhexidine gluconate
- **BEHAVIORAL:** Education + Household supplies

## Key facts

- **NCT ID:** NCT06210594
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-01
- **Primary completion:** 2025-11-14
- **Final completion:** 2025-11-14
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210594, "Staph Intervention for Effective Local Defense". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06210594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*